Randy Baddo

Randy Baddo has a diverse range of work experience, primarily in financial planning and analysis roles. Randy started their career as a Financial Analyst at Intel in 2001 and then moved on to Applied Materials in 2004, where they served as a Financial Planning & Analysis and Expatriate. In 2011, they joined Genentech as a Group Controller, providing finance support to the VP's of Clinical Operations and Clinical Science. Randy then worked at Illumina and Orexigen Therapeutics in Financial Planning & Analysis positions before joining Neurocrine Biosciences in 2018. At Neurocrine Biosciences, they played a crucial role in implementing key planning processes and financial reporting systems. In 2020, they joined RanMar Capital as the Chief Financial Officer, a position they currently hold. Randy will be joining ITJuana as their Chief Financial Officer in 2023. Throughout their various roles, Randy has consistently demonstrated their expertise in financial analysis, decision support, and process improvement.

Randy Baddo's education history includes attending Northeastern University, where they pursued a Bachelor of Applied Science (B.A.Sc.) degree in Finance & Accounting Management. The specific years during which they attended this university are not provided. Additionally, Randy also had an educational experience at The American University of Paris; however, no information regarding the degree or field of study pursued at this institution is given.